[ad_1]
Scientists have suggested that the chemical secretions responsible for the acquisition of pink-colored brain tumors could help eliminate cancerous tumors safely.
Scientists have given a number of patients suspected of having a rapidly growing tumor in brain cells containing a 5-ALA compound, a substance abundantly present in rapidly growing cancer cells.
Tumors are characterized by glial cells or glands because they infect cells of the same name. These cells are found in the connective tissues responsible for joining or connecting tissues and organs. The study found that the predominantly pink substance was found in people with the most serious cancers, and researchers hope that these secretions will help surgeons distinguish between cancer cells and the sound of tissue. cerebral.
The treatment of these tumors, the most common type of cancerous brain tumor at the origin of the death of British Minister Tessa Joel, requires surgery to remove as much tumor as possible, but the diagnosis of this type of cancer is often inaccurate.
In the new trial, 99 patients suspected of developing fast-growing tumors in brain cells received a 5-ALA drink before surgery.
Researchers previously said the substance was found in fast-growing cancer cells because of the lack of enzyme needed to break down the chemical, and surgeons used a microscope to see the tissue lit while eliminating the brain tumors.
The researchers indicated that the study focused primarily on people with advanced glaucoma, but further efforts were needed to expand the research sample base and to prepare for a more in-depth study involving more patients with advanced glaucoma. lower risk of these tumors, so that's the new method.
It is necessary to test other types of orientation documents that show surgeons less dangerous cancer cells and help them distinguish them from healthy brain tissue.
The next steps in this trial include the use of 5-ALA in children with brain cancer or to help surgeons identify scar tissue in patients who have relapsed after treatment for the cancer.
Earlier this year, the National Institute of Health and Clinical Excellence approved the use of 5-ALA prior to surgery in people with brain cancer.
The research was presented at a conference of the National Cancer Research Institute, which takes place from 4 to 6 of the month of this month.
Source: The bbc
[ad_2]
Source link
